全国免费服务热线:021-64330607 服务时间 9:00-22:00 新浪微博 腾讯微博 注册 当前用户:[USERNAME],用户ID:[USERID] 用户中心 退出 收藏本页

acta orthopaedica

来源:作者:热度:Loading...日期:2014-01-21, 03:58 PM

期刊名称 acta orthopaedica 

中文名称 ACTA ORTHOP   
学科分类 医学-骨科 出版周期 双月刊   
审稿速度 不详(这个需要查下,哪怕编出来一个)

投稿命中率  不详(这个需要查下,哪怕编出来一个)   
期刊主页 http://informahealthcare.com/loi/ort     
ISSN 号 (printed 请直接写中文,印刷版): 1745-3674. ISSN (electronic 电子版): 1745-3682     
IF 趋势 2005   2006    2007    2008    2009    2010    2011    2012   
           1.157   1.305   1.285   1.762   1.909    1.897   2.168   2.736   
被收录情况 1. Science Citation Index 
                  2. Science Citation Index Expanded   庄请注意 Science Citation Index (代表sci)Science Citation  Index Expanded(代表scie)  请直接用中文就好,我们的信息就是要给客户一个所见即所得的信息,要学者引导客户,在没有其他信息支持的情况下,我们的信息那就是正确的信息,即使可能我们的信息可能缺少理论依据。
                  3. Current Contents - Clinical Medicine 
                  4. Current Contents - Life Sciences 
                  5. BIOSIS Previews   
PubSci评语 北欧骨科联合会的正式刊物,一审在六周左右。无版面费。   
期刊简介 创刊于1930年,即以前的Acta Orthopaedica Scandinavica,北欧骨科联合会的正式刊物,主要发表骨科及相关子学科领域的基础研究和临床研究成果。   
投稿注意事项 特别提醒:无版面费。也没有所谓的open access
我前面邮件中提到,大体浏览下guideline ,比如我用了1分钟浏览了下,可以写下面几个关键点,供参考
1 摘要不超过200word,分段式摘要
2 插入行号  
这样的话可以避免投稿被send back,当然不可能仔细看,就是浏览基础投稿中可能会遇到问题的地方,比如说全文字数,摘要字数限制,图片保存格式,文章的讨论的什么的,怎么写都没有人管的,不会在初审的时候被退回。所以这个浏览下,挑几点就好
一般注意事项:
Short Author Guidelines
Submission of manuscripts
Manuscripts should be submitted online, www.actaorthop.org. Authors are encouraged to provide the names, addresses, and e-mail of potential reviewers. Note the following points:
a.The manuscript should be prepared according to Uniform Requirements for Manuscripts submitted to Biomedical Journals (www.icmje.org). American spelling is preferred.
b.Authors submitting a paper do so on the understanding that it has not been published and is not being considered for publication elsewhere. The authors should provide a statement about previous submissions and reports that might be regarded as duplicate publication of the same or a similar paper. Copies of that study should be submitted with the paper.
c.Authors should provide a description of their individual contributions to the study.
d.Reports of randomized controlled trials should comply with the CONSORT statement (www.consort-statement.org).
e.The study protocol (e.g., the protocol approved by the ethics committee) and a completed CONSORTchecklist and flowchart should be appended to the manuscript.
f.All clinical trials submitted for consideration should have been registered in a public trials registry.
g.Authors of systematic reviews and meta-analyses are advised to consult the consensus statements QUORUM and MOOSE for randomized trials and observational studies, respectively (see JAMA 2000; 283: 2008–12 and www.consort-statement.org/QUOROM.pdf).
h.All documents with original data of relevance to the submitted manuscript should be stored and be retrievable on request for a minimum of 10 years. Authors are encouraged to include a copy of raw data in electronic form and/or make these data available via the internet.

 

Manuscript layout
Title
The title should include information on the results of the investigation, including the number of patients, average follow-up, and animal or cadaver experiments. The first name, middle initial(s), and last name of each author should be given with department affiliations as well as the name, complete address and e-mail of the corresponding author.
Abstract
The abstract should not exceed 250 words. It should consist of 4 parts: Background and purpose, Patients/material/animals and methods, Results and Interpretation.
Introduction
The introduction should focus on the state of knowledge at the beginning of the study. The aims and main hypothesis of the study should be stated clearly. Only in exceptional cases should it exceed one typewritten page. Case reports. These should be short, include the Case history and Discussion without an Introduction.
Patients/material/animals and methods
The selection of subjects and the inclusion or exclusion criteria should be described. Subjects who declined to participate, withdrawals and those with incomplete follow-up should be accounted for. Describe in detail how the measurements were made and the techniques used.
Statistics
All statistical methods should be mentioned. Unusual methods should be referenced. The tests should be two-sided, unless the use of one-sided tests is justified. No data should be removed, imputed, weighted, adjusted or trimmed unless they are specifically described and justified and its consequences are given. 
Hypothesis tests (p-values). These tests should be used, in combination with a defined effect size and when statistical power has been considered. Give p-values with real numbers, if these are greater than 0.001 (1 digit except zeros), otherwise use ‘p < 0.001’. Do not use ‘ns’, ‘p > 0.05’ or asterisks. In most instances, the 95% confidence intervals should be given, especially in exploratory analyses and when estimating the effects or differences.
Ethics
Approval by the local ethics committee should be stated with date of issue and registration number.
Results
Do not give the same data in more than one way. When summarizing the data, always include measures of variability and the number of subjects. Give the median and range—e.g., 60 (35–70) years, the mean and standard deviation—59 (SD 15) years, and the frequencies for nominal data. The results of matched data should be given in relevant form (e.g., the distribution of pairwise differences). Percentages should not be used if the sample size is less than 100.
Discussion
This section should contain a critical discussion of the results—e.g., the quality of the data (selection and information bias) and adequacy of the statistical analysis (confounding bias). It should also assess the relevant literature for or against the findings and if possible, the conclusions as regards clinical application or further research. Discuss, do not recapitulate, your results.
Tables
Each table should be self-explanatory, with an adequate title and a logical presentation of the data. Abbreviate words in the columns and explain in footnotes. Each column heading for numerical data should include the unit of measurement. Use SI units. Avoid unnecessary decimals! It is seldom advisable to use more than 2 digits for biologic measurements.
Digital illustrations
Should be used. A scanned picture or digital photo should usually be about 50 × 70 mm with a resolution of 300 dpi, which gives an uncompressed file size of 2 MiB in color and 500 KiB in gray-scale. A black and white drawing or graph may be scanned in 800 dpi bitmap, i.e. 1 bit TIFF. A 70 × 70 mm graph gives a file size of 600 KiB The preferred format is a TIFF-file. The resolution of web illustrations (gif) is usually too poor. Color photos should be in CMYK colors. The cost of color will be paid by Acta. Embed moderately JPEG compressed versions of your illustrations in your online submitted PDF file. These illustrations will not be used for production. Highlights, arrows and letters may be added to digital photos but keep a clean version of the photo for the layout process. Acta prefers to add these as a separate layer. For digital graphs, use a graphics program that can export EPS-files. Avoid frames around diagrams, diagrams with perspective drawing, and bar graphs or histograms (use tables). Symbols should be consistent throughout a series of figures. Each axis should be horizontally labelled, with a description of the variable it represents. Use sans serif letters (Arial or Helvetica). Make diagrams in black-and-white with gray or color areas, but avoid complex patterns.
Authors contributions
Describe in short what each author did.Acknowledgments
Technical help and financial or other sponsorship may be acknowledged. Conflicts of interest, if any, should be clearly stated in the manuscript on submission. When the manuscript is accepted for publication, all authors are asked also to sign a conflict of interest statement.
References
We prefer the references to be cited by name and year (chronologically) of publication in the text instead of giving their numbers, i.e. one author, two authors or author et al. and year. Thus, the list of references should be given in alphabetical order.
Submission
Create an Adobe Portable Document File (PDF) of your full manuscript. You will need the Adobe Acrobat Writer Program or similar PDF creator program installed on your computer. We recommend that you write your manuscript as a Microsoft Word .le and embed all images, tables, figures etc. within the one file. Now convert the Microsoft Word Document to a PDF file by choosing the appropriate icon in the task bar of the Microsoft Word Application. Alternatively, right hand click on the icon of your manuscript file and choose, convert to Adobe PDF. If you do not have the Adobe PDF writer installed on your computer, you can use the ‘try it for free’ feature found on the Adobe website at this address: http://createpdf.adobe.com/ Important: Please line number the Microsoft Word document before converting to PDF by following the procedure below.
Insert line numbers:
1. Switch to print layout view.
2. Do one of the following:
• To add line numbers to the entire document, click Select All on the Edit menu.
• To add line numbers to part of a document, select the text you want to number.
• To add line numbers to existing sections, click in a section or select multiple sections.
3. On the File menu, click Page Setup, and then click the Layout tab.
4. If you’re adding line numbers to part of a document, click Selected text in the Apply to box.
5. Click Line Numbers.
6. Select the Add line numbering check box, and then select the options you want.    
编辑部信息 所在地: 隆德 国家 瑞典   
  Editor: 
Anders Rydholm 
Acta Orthopaedica 
Department of Orthopedics 
Lund University Hospital 
SE-221 85, Lund, Sweden 
Tel: +46 46 17 15 96 
Fax: +46 46 18 44 54 
E-mail: acta.ort@med.lu.se 
Website: www.actaorthop.org 
Deputy Editor: 
Peter A. Frandsen 
Department of Orthopedics 
Odense University Hospital 
Sdr Boulevard 29 
DK-5000 Odense C 
Denmark 
E-mail: peter.frandsen@ouh.fyns-amt.dk 
Co-Editors: 
Per Aspenberg - Linköping, Sweden
Nils Hailer - Uppsala, Sweden 
Ivan Hvid - Århus, Denmark
Yrjö Konttinen - Helsinki, Finland 
Urban Rydholm, Lund, Sweden
Bart A. Swierstra - Nijmegen, The Netherlands 
Eivind Witsö - Trondheim, Norway
Rolf Önnerfält - Lund, Sweden 

Statistics Consultant: 
Jonas Ranstam - Lund, Sweden
Production Manager: 
Kaj Knutson - Lund, Sweden
Editorial Board: 
Li Felländer-Tsai - Stockholm, Sweden 
Peter Frandsen - Odense, Denmark 
Jan Erik Madsen - Oslo, Norway 
Aare Märtson - Tartu, Estonia 
Jan B.A. van Mourik - Veldhoven, The Netherlands 
Gauti Laxdal - Reykjavik, Iceland 
Jarkko Pajarinen - Helsinki, Finland 
Anders Rydholm - Lund, Sweden 
Kees Verheyen - Zwolle, The Netherlands 
Ebbe Stender Hansen, Århus, Denmark 
Deputies: 
Kristina Åkesson - Malmö, Sweden 
Jan-Magnus Björkenheim - Helsinki, Findland 
Jon Fevang - Bergen, Norway 
Rein Raie - Tallin, Estonia 
Otto Robertsson - Reykjavik, Island 
Kjeld Söballe - Århus, Denmark 
Jan A. N. Verhaar - Rotterdam, The Netherlands
Read More: http://informahealthcare.com/page/ort/EditorialAdvisoryBoard 

网友投稿经验整理:
Status: Under review 
Submission number: 1 
Date Received: 2012-04-12 
Weeks under review: 6 
Requests sent: 2 
Reviewers agreed: 1 
Reviews completed: 1
贡献者: ppswppp
Key to progress report 

Date received: The date that the manuscript was received at the Editorial Office. 

Weeks under review: The time from 'date received' until today. 

Requests sent: How many external reviewers have been approached to review the manuscript but have not yet responded to the request or have declined to act as reviewer. 

Reviewers agreed: How many external reviewers have agreed to review the manuscript but have not yet returned their review. 

Reviews completed: How many external reviews have been completed and returned. 
贡献者:ppswppp

扫描二维码
关注Pubsci微信
微信公共账号:pubsci888

关键词:论文翻译润色,论文评估,SCI投稿,SCI期刊发表,医生出国进修